Jump to content

Jessica Borger

From Wikipedia, the free encyclopedia

Jessica Geraldine Borger
Jessica Borger
Born
Alma materUniversity of South Australia, University of Edinburgh, University College London, Monash University
AwardsASI Margaret Baird Women in Immunology Award, ASI Social Impact Award, ASI Cheers-Buchan Education Award, Monash University Vice-Chancellors Award for Diversity and Inclusion, Monash University Dean's Award for Education - teams, Monash University Dean's Award for Diversity and Inclusion
Scientific career
FieldsImmunology

Jessica Geraldine Borger is an Australian T Cell immunologist, lecturer and graduate course coordinator at the Central Clinical School, Monash University.[1] Her research has added to the understanding of the molecular mechanisms of T cell function.[2] Additionally, Borger is a news and commentary editor for Immunology & Cell Biology[3] and a guest associate editor for Frontiers in Immunology,[4] and a reviewer for several academic journals.[1] Borger also advocates for gender equality in science, technology, engineering and mathematics (STEM) in her position a member of the Gender Equity, Diversity and Inclusion committee of the Central Clinical School at Monash University.

Education

[edit]

Borger started her studying towards her undergraduate degree when she was 21 years old.[5] She received a bachelor's degree in medical and pharmaceutical biotechnology from the University of South Australia.[1] Eight years after completing her bachelor's degree, she moved to the UK to begin her PhD at University College London after being awarded a highly competitive Medical Research Council PhD scholarship by the National Institute of Medical Research.[1][5] During her PhD, she began researching T Cell function with Rose Zamoyska, specifically investigating the localisation of cell surface receptors and intracellular proximal TCR signaling molecules in CD8 T cells during memory formation.[1]

Career

[edit]

Research

[edit]

Between completing her bachelor's degree and starting her PhD, Borger worked as a Molecular Biologist for GRMicro (2002 - 2003), and for Arrow Therapeutics as a Drug Discovery Scientist (2003 - 2006).[6]

Borger undertook her postdoctoral training on a Medical Research Council fellowship from 2010–2016 at the University of Edinburgh with Prof Zamoyska, investigating the role of Caveolin-1 in T cell cholesterol homeostasis, integrin signaling and exosome complex biogenesis.[1]

In 2016, Borger took a position in the Central Clinical School at Monash University as a senior postdoctoral researcher. In this position, Borger has been researching gamma delta T cell development, activation and function as potential targets of therapeutic intervention of lung disorders.[1][4] Additionally, Borger was awarded a CASS Foundation Medicine/Science grant to research the design of novel CAR-T therapy approaches in the lung using novel intracellular checkpoint blockade targets.[1][7] In 2017, she was awarded the IgV Best Postdoctoral Speaker Award by the Australia and New Zealand Society of Immunology, the Best Presentation Prize by the Immunology Alfred Hospital.,[8][9] and in 2018 the Best Speaker Award at the International Conference on Innate Lymphoid Cells in Japan.[10]

In 2019, Borger became lecturer and course-coordinator of graduate studies at Monash University. In this role, she created a master's course in translational research.[1] In the same year, Borger was the first recipient of the Margaret Baird Women in Immunology Award by the Australia and New Zealand Society for Immunology.[11][12]

Science communication and gender equality advocacy

[edit]

Borger is an advocate for gender equality in STEM and science communicator. She has written articles for Women's Agenda,[13] The Conversation,[6] Women in STEMM Australia,[14] and SoapboxScience.[15] In 2018, Jessica Borger was awarded the Veski Inspiring women STEM Sidebyside scholarship.[16][1][4]

From 2018, Borger has sat on both the A+ Gender Equity committee of the A+ Alfred Research Alliance at the Alfred Hospital and the Gender, Equity, Diversity and Inclusion (GEDI) committee at the Central Clinical School at Monash University.[17][1] The GEDI committee conducted a survey to investigate problems and concerns with GEDI issues in the school[18] and ran a survey in 2020 to understand the impact of COVID-19 on researchers with a gendered lens applied.[19] In 2020 Borger, as a member of the Equity in Medical Research Alliance (EMRA) was involved in the creation of a position paper to mitigate the gendered impacts of the COVID-19 pandemic on the medical research workforce.[20]

Publications

[edit]

Borger's published works include:

References

[edit]
  1. ^ a b c d e f g h i j k "Jessica Borger". Monash University. Retrieved 16 August 2020.
  2. ^ "Jessica Borger". STEM Women. Retrieved 16 August 2020.
  3. ^ "Immunology & Cell Biology". Wiley Online Library. doi:10.1111/(ISSN)1440-1711. Retrieved 22 August 2020.
  4. ^ a b c "Loop | Jessica Borger". loop.frontiersin.org. Retrieved 16 August 2020.
  5. ^ a b Watton, Isla (29 May 2019). "You are a unique product of your own passions, drive and opportunities: Meet Jessica Borger". SoapboxScience. Retrieved 17 August 2020.
  6. ^ a b "Jessica Borger". The Conversation. Retrieved 17 August 2020.
  7. ^ "Jessica Borger". Monash Lens. Retrieved 17 August 2020.
  8. ^ "Best Postdoctoral Speaker Award". Monash University. Retrieved 17 August 2020.
  9. ^ "Best Presentation Prize". Monash University. Retrieved 17 August 2020.
  10. ^ "Best Speaker Award - The 3rd International Conference on Innate Lymphoid Cells, Tokyo, Japan". Monash University. Retrieved 22 August 2020.
  11. ^ "Margaret Baird Women in Immunology Lectureship". Monash University. Retrieved 16 August 2020.
  12. ^ Media, Gloss Creative. "ASI 2019 – Awards and Special Honours". www.immunology.org.au. Retrieved 16 August 2020.
  13. ^ "Dr Jessica Borger, Author at Women's Agenda". Women's Agenda. Retrieved 17 August 2020.
  14. ^ Australia, Women in STEMM (5 December 2018). "Once you've left can you really break back in?". Women in STEMM Australia. Retrieved 17 August 2020.
  15. ^ Watton, Isla (29 May 2019). "We need to return the 'S' to STEM with the very important 'women' prefix". SoapboxScience. Retrieved 22 August 2020.
  16. ^ "2018 Leading the Way Participants | veski". www.veski.org.au. Retrieved 17 August 2020.
  17. ^ "Central Clinical School News Blog: Eye on GEDI: Gender, Equity, Diversity and Inclusion at CCS". Central Clinical School News Blog. 27 July 2018. Retrieved 17 August 2020.
  18. ^ "Conference Committee". Lorne Infection & Immunity 2021. Retrieved 17 August 2020.
  19. ^ "Thanks to COVID, there's a gender disconnect in discovery". Monash Lens. 25 June 2020. Retrieved 22 August 2020.
  20. ^ "WiSPP". WiSPP. Retrieved 22 August 2020.
  21. ^ Borger, Jessica G.; Lau, Maverick; Hibbs, Margaret L. (2019). "The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease". Frontiers in Immunology. 10: 1597. doi:10.3389/fimmu.2019.01597. ISSN 1664-3224. PMC 6637857. PMID 31354734.
  22. ^ Coakley, Gillian; Wright, Mark D.; Borger, Jessica G. (2019). "Schistosoma mansoni-Derived Lipids in Extracellular Vesicles: Potential Agonists for Eosinophillic Tissue Repair". Frontiers in Immunology. 10: 1010. doi:10.3389/fimmu.2019.01010. ISSN 1664-3224. PMC 6514238. PMID 31134080.
  23. ^ Borger, Jessica G.; Morrison, Vicky L.; Filby, Andrew; Garcia, Celine; Uotila, Liisa M.; Simbari, Fabio; Fagerholm, Susanna C.; Zamoyska, Rose (1 August 2017). "Caveolin-1 Influences LFA-1 Redistribution upon TCR Stimulation in CD8 T Cells". Journal of Immunology. 199 (3): 874–884. doi:10.4049/jimmunol.1700431. ISSN 1550-6606. PMC 5523581. PMID 28637901.
  24. ^ Borger, Jessica G.; Zamoyska, Rose; Gakamsky, Dmitry M. (January 2014). "Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells". Immunology Letters. 157 (1–2): 16–22. doi:10.1016/j.imlet.2013.11.005. ISSN 0165-2478. PMC 3931270. PMID 24263053.
  25. ^ Libri, Valentina; Helwak, Aleksandra; Miesen, Pascal; Santhakumar, Diwakar; Borger, Jessica G.; Kudla, Grzegorz; Grey, Finn; Tollervey, David; Buck, Amy H. (3 January 2012). "Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target". Proceedings of the National Academy of Sciences. 109 (1): 279–284. Bibcode:2012PNAS..109..279L. doi:10.1073/pnas.1114204109. ISSN 0027-8424. PMC 3252920. PMID 22184245.